Biotech Mission Therapeutics announces publication in Nature Reviews Drug Discovery of article highlighting how neurodegenerative diseases can be tackled by enhancing mitophagy January 15, 2025
Biotech FDA accepts Biologics License Application for subcutaneous maintenance dosing of Leqembi® (lecanemab-irmb) in the US January 14, 2025
Biotech Enea TECH and Biomedical Foundation invests €15 million in Tethis to develop new diagnostic methods in oncology using liquid biopsy January 14, 2025
Biotech REGENXBIO and Nippon Shinyaku Announce Exclusive Partnership to Develop and Commercialize RGX-121 and RGX-111 for MPS Diseases January 14, 2025
Biotech Illumina launches pilot proteomics program with UK Biobank and biopharma collaborators to analyze 50,000 samples January 13, 2025
Biotech Outrun Therapeutics expands leadership team with appointment of Matthew Fyfe as Chief Scientific Officer January 13, 2025
Biotech Expert Systems and Traws Pharma Report Breakthrough in H5N1Bird Flu Antiviral Program January 13, 2025
Biotech Kelun-Biotech Announce Exclusive License Agreement For SKB378/HBM9378, an Anti-thymic Stromal Lymphopoietin (TSLP) Monoclonal Antibody (mAb). January 13, 2025